Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carey E Gleason

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Menopause (New York, N.Y.)|December 31, 2011
Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?Carey E Gleason, N Maritza Dowling, Elliot Friedman, et al.
Annals of the New York Academy of Sciences|July 19, 2005
Clinical pharmacology and differential cognitive efficacy of estrogen preparationsCarey E Gleason, Cynthia M Carlsson, Sterling Johnson, et al.
International Psychogeriatrics|August 29, 2019
Depressive role impairment and subthreshold depression in older black and white women: race differences in the clinical significance criterionMary F Wyman, Erin M Jonaitis, Earlise C Ward, et al.
Maturitas|November 3, 2009
Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user biasWhitney Wharton, Maritza Dowling, Christine M Khosropour, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 6, 2008
Standardized note template improves screening of firearm access and driving among veterans with dementiaNoelle K LoConte, Carey E Gleason, Gail Gunter-Hunt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to knowClaire M Erickson, Nathaniel A Chin, Sterling C Johnson, et al.
Current Psychiatry Reviews|August 31, 2013
Neurobiological Underpinnings of the Estrogen - Mood RelationshipWhitney Wharton, Carey E Gleason, Sandra R M S Olson, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 11, 2024
Qualitative Message Development to Motivate Quitting Smoking in Older Adults: Dementia May Motivate QuittingAdrienne L Johnson, Sara Doyle, Carey E Gleason, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 27, 2016
Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive ImpairmentCarey E Gleason, N Maritza Dowling, Susan Flowers Benton, et al.
Physical Therapy|November 16, 2013
Declining cognition and falls: role of risky performance of everyday mobility activitiesBarbara L Fischer, Carey E Gleason, Ronald E Gangnon, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Menopause (New York, N.Y.)|December 31, 2011
Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?Carey E Gleason, N Maritza Dowling, Elliot Friedman, et al.
Annals of the New York Academy of Sciences|July 19, 2005
Clinical pharmacology and differential cognitive efficacy of estrogen preparationsCarey E Gleason, Cynthia M Carlsson, Sterling Johnson, et al.
International Psychogeriatrics|August 29, 2019
Depressive role impairment and subthreshold depression in older black and white women: race differences in the clinical significance criterionMary F Wyman, Erin M Jonaitis, Earlise C Ward, et al.
Maturitas|November 3, 2009
Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user biasWhitney Wharton, Maritza Dowling, Christine M Khosropour, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 6, 2008
Standardized note template improves screening of firearm access and driving among veterans with dementiaNoelle K LoConte, Carey E Gleason, Gail Gunter-Hunt, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to knowClaire M Erickson, Nathaniel A Chin, Sterling C Johnson, et al.
Current Psychiatry Reviews|August 31, 2013
Neurobiological Underpinnings of the Estrogen - Mood RelationshipWhitney Wharton, Carey E Gleason, Sandra R M S Olson, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 11, 2024
Qualitative Message Development to Motivate Quitting Smoking in Older Adults: Dementia May Motivate QuittingAdrienne L Johnson, Sara Doyle, Carey E Gleason, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 27, 2016
Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive ImpairmentCarey E Gleason, N Maritza Dowling, Susan Flowers Benton, et al.
Physical Therapy|November 16, 2013
Declining cognition and falls: role of risky performance of everyday mobility activitiesBarbara L Fischer, Carey E Gleason, Ronald E Gangnon, et al.
Pageof 13